Free U.S. shipping $175+

VIP — Novaryn Research
Hover to zoom
Immune & InflammatorySynthetic vasoactive intestinal peptide (28 amino acids)

VIP

$69.99
10 mg

Vasoactive intestinal peptide (VIP) is a 28-amino-acid neuropeptide belonging to the secretin/glucagon peptide superfamily.

It signals through the class B G-protein-coupled receptors VPAC1 and VPAC2, and is studied in laboratory research on smooth-muscle and secretory physiology, circadian signaling in the suprachiasmatic nucleus, and immune-cell modulation.

Research areas
VPAC receptor signalingNeuroimmune researchCircadian biologySecretory physiology models
Form: Lyophilized (freeze-dried)
Compound class
Synthetic vasoactive intestinal peptide (28 amino acids)
Research category
Immune & Inflammatory
SKU
NVR-VIP-10MG
Alternate name
Vasoactive Intestinal Peptide
Appearance
White lyophilized powder
Storage
Store at 2–8 °C. Protect from light.
Research use only
Strength
10 mg$69.99$7.00/mg
1
$69.99per 10 mg$7.00/mg

For research use only — not for human or animal consumption.

Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.

Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know

More detail on VIP.

Analytical values reflect per-lot documentation and appear once a batch is released.

Compound
VIP is one of the more broadly distributed neuropeptides, with roles described across enteric, central, and immune systems. That breadth makes it a useful reference ligand for class B GPCR pharmacology, where cyclic-AMP accumulation is the standard readout. Research applications include VPAC1/VPAC2 selectivity assays, circadian-rhythm studies in hypothalamic models where VIP signaling synchronizes neuronal populations, and immune-cell cultures examining cytokine profiles. The peptide is also used as a comparator when characterizing PACAP-family ligands.
Peptide class
Synthetic vasoactive intestinal peptide (28 amino acids)
Mechanism (research context)
VIP signals through VPAC1 and VPAC2 G-protein-coupled receptors and has been studied in cellular systems for effects on cyclic-AMP signaling, immune-cell modulation, and neuroendocrine readouts.
Why it is studied
VIP is a foundational neuropeptide and one of the most extensively studied members of the secretin/glucagon peptide superfamily.
Current areas of research
VPAC receptor signalingNeuroimmune researchCircadian biologySecretory physiology models

Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.

Scientific background

VIP was first isolated by Said and Mutt in the early 1970s from intestinal tissue and has since become one of the most extensively studied neuropeptides.

Its receptors, VPAC1 and VPAC2, are widely characterized in neuroendocrine and immunology literature.

Related

Related research materials

View all →
VIP
10 mg · $69.99
Notify me when available